WHONET علیرضا ترکی دانشجوي PhD ميکروب شناسی بالینی

Slides:

Advertisements

Similar presentations

The epidemic intelligence meeting Katrine Borgen Department of Infectious Disease Epidemiology Norwegian Institute of Public Health EpiTrain V, Vilnius.

Advertisements

Massachusetts Department of Public Health

Module 4: Final Case Study # 4-CS-1. Case Study: Instructions v Try this case study individually. v We’ll discuss the answers in class. # 4-CS-2.

Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.

Systems interoperability for a better treatment and surveillance of infections ECCMID Symposium Interest of IT solutions to improve patient management.

Antimicrobial Resistance Surveillance Latin America

Field Epidemiology in Practice: A Hospital Outbreak of Acinetobacter Suzanne Beavers, M.D EIS Officer Kentucky Department for Public Health.

The Antimicrobial Resistance Surveillance Programme of Vietnam: Acute respiratory tract infections Do khang Chien, MD, PhD Nguyen thi phuong cham, BSPh.

WHONET Part II Expert System Dr.T.V.Rao MD 1. Isolate alerts WHONET now permits the user to take advantage of pre-defined or user-defined expert rules.

WHO Collaborating Centre for Surveillance of Antimicrobial Resistance Brigham and Women’s Hospital, Boston WHONET and BacLink Laboratory-based surveillance.

WHO Global Salm-Surv: A Global Salmonella Surveillance Network World Health Organization, Geneva Centers for Disease Control and Prevention, Atlanta Danish.

Laboratory Training for Field Epidemiologists Strengthening Laboratory and Epidemiology Collaboration Introduction May 2007.

Epidemiology Tools and Methods Session 2, Part 1.

WHO COLLABORATION | September 13, | WHO Indonesia Collaboration with Animal Health.

Do Physicians Find Our AST Reports As Confusing As We Do? Louis B. Rice, M.D. Louis Stokes Cleveland VA Medical Center and Case Western Reserve University.

Zunilda Djanun*, Rudyanto S**, Yulia Rosa***, *Dept. Clinical Pharmacology FMUI/CMH, **ICU CMH, *** Dept. Clinical Microbiology FMUI.

Antimicrobial Resistance patterns among nosocomial gram negative bacilli by E-test and disc diffusion methods in Sina and Imam Hospital.

UNCLASSIFIED LTC John M. Scherer/(301) 1 March 2010 Genesis of Clinical Microbiology in the CSH - Afghanistan 2002 LTC.

Susceptibility (Sensitivity) Testing: Results Pharmaceutical Microbiology – Practical Course Semester One_ Sensitivity Results & MIC Broth Dilution/

Salmonella Reference Laboratory Epidemiology of Salmonella enterica from C. O’ Hare 1, N. Delappe 1, G. Doran 1, D. Morris 2, D. Kilmartin 2,

European Centre for Disease Prevention and Control

Antimicrobial resistance surveillance in Ireland Results of invasive Klebsiella pneumoniae infection (blood/CSF) surveillance, 2009 **** Data as of 01/12/2010.

Országos Epidemiológiai Központ National Center for Epidemiology, Budapest, Hungary Activities in Hungary for preventing AMR and controlling HCAI Emese.

EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.

By: Dr. Khalid El Tohami. Objectives  At the end of the session the student should be able to:  Define epidemiology, what are the basic measurements.

Understanding Epidemiology Introduction to Epidemiology and Epidemiological Concepts.

Dr.Mowna Karthick M.D MICROBIOLOGY

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Reasons for non use of ACTs

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Antibiotics sensitivity of microorganism causing nosocomial infections

G. Cornaglia, A. Lönnroth, M. Struelens

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.

A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes G. Kronvall, G. Kahlmeter, E.

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98 J. Robert, E. Cambau, K. Grenet, D.

R. Cantón Clinical Microbiology and Infection

Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program M.

C.G. Giske, C. Borén, B. Wretlind, G. Kronvall

Clinical Microbiology and Infection

Holt Hanne M. , Søgaard Per , Gahrn-Hansen Bente

H. Adibhesami, M. Douraghi, M. Rahbar, A. Abdollahi

D.E. Low Clinical Microbiology and Infection

R. Cantón, M. Akóva, Y. Carmeli, C. G. Giske, Y. Glupczynski, M

The need for new antibiotics

Making sense of antimicrobial use and resistance surveillance data: application of ARIMA and transfer function models D.L. Monnet, J.-M. López-Lozano,

…monitoring trends in antimicrobial resistance in Canada

Control of infections due to extended-spectrum β-lactamase-producing organisms in hospitals and the community R.E. Warren, G. Harvey, R. Carr, D. Ward,

S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter

Decreasing rates of resistance to penicillin, but not erythromycin, in Streptococcus pneumoniae after introduction of a policy to restrict antibiotic.

Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions M. Sjölund, S. Bengtsson, J. Bonnedahl,

W. -L. Yu, M. -F. Lee, H. -J. Tang, M. -C. Chang, J

Prevalence of colonisation with third-generation cephalosporin-resistant Enterobacteriaceae in ICU patients of Heidelberg University Hospitals H. von.

Jacques Sirot, Patrice Courvalin, Claude-James Soussy

J. Garau Clinical Microbiology and Infection

T.M. File Clinical Microbiology and Infection

Outbreak of infection with high-level gentamicin-resistant Enterococcus faecalis (HLGRE) in a Norwegian hospital Ø. Wendelbo, R. Jureen, G.E. Eide, A.

Can β-lactams be re-engineered to beat MRSA?

C. Oprica, C.E. Nord Clinical Microbiology and Infection

V. Vlahović-Palčevski, U. Dumpis, P. Mitt, J. Gulbinovič, J. Struwe, G

Development of the EUCAST disk diffusion antimicrobial susceptibility testing method and its implementation in routine microbiology laboratories E. Matuschek,

…monitoring trends in antimicrobial resistance in Canada

Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents Clinical Microbiology and Infection Volume.

European recommendations for antimicrobial resistance surveillance

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

EARS-Net data on Antimicrobial Resistance in Ireland, Q

Presentation transcript:

WHONET علیرضا ترکی دانشجوي PhD ميکروب شناسی بالینی دانشگاه علوم پزشکي ایران Ar.torki@yahoo.com

The principal goals of the software are: What is WHONET? WHONET is a free software developed by the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance for laboratory-based surveillance of infectious diseases and antimicrobial resistance. The principal goals of the software are: • to enhance local use of laboratory data; • to promote national and international collaboration through the exchange of data.

WHONET analytical tools facilitate: WHONET can be used by individual laboratories or as part of a national and international surveillance network. At present, the software, available in 17 languages, is used in over 90 countries around the world managing data from over 1000 clinical, public health, veterinary, and food laboratories. WHONET analytical tools facilitate: • the understanding of the local epidemiology of microbial populations; • the selection of antimicrobial agents; • the identification of hospital and community outbreaks; and • the recognition of quality assurance problems in laboratory testing. • Developed since 1989 by the WHO Collaborating Centre for Surveillance of Antimicrobial Resistance.

What can WHONET do? Installing WHONET Laboratory Configuration WHONET has five main components: Installing WHONET Laboratory Configuration Data Entry Data Analysis BacLink website: www.who.int/drugresistance/whonetsoftware

WHONET 5.6

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology

The graph depicts the graph for the department of surgery. . Distribution of MRSA isolates by department. Only the first isolate per patient is included. The graph depicts the graph for the department of surgery.

Monthly distribution of patients with Acinetobacter baumannii over a two year period.

%RIS and test measurement statistics for K. pneumoniae. %Resistant results are shown to the left for all antimicrobials, including the 95% confidence interval. The graph to the right depicts the distribution of disk diffusion zone diameters around the gentamicin disk.

Ciprofloxacin %Resistant results for all Enterobacteriaceae.

Scatterplot comparison of gentamicin and amikacin results for K Scatterplot comparison of gentamicin and amikacin results for K. pneumoniae. To the left is a comparison of the disk diffusion zone diameter results. To the right is the comparison using the test interpretations – resistance, intermediate, and susceptible.

A summary of the microbiological alerts observed in the analyzed data A summary of the microbiological alerts observed in the analyzed data. Categories of alert include “Quality control”, “Important species”, “Important resistance”, “Send to a reference laboratory”, and “Alert the infection control” among others.

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology

12/9/2018 Sina Mobasherizadeh Ph.D Candidate of Bacteriology